Model
Edge
Alnylam Pharmaceuticals, Inc.
0001446125
Filing type
4
Filing date
Mar 5, 2026
Updated
Mar 6, 2026 ยท 2:13 PM
Copy reference
Filing
4
Statement of Changes in Beneficial Ownership